Familial Alzheimer disease mutation identifies novel role of SORLA in release of neurotrophic exosomes
Authors
- Kristian Juul-Madsen
- Ina-Maria Rudolph
- Jemila P. Gomes
- Katrina Meyer
- Peter L. Ovesen
- Malgorzata Gorniak-Walas
- Marianna Kokoli
- Narasimha S. Telugu
- Malthe vonTangen Sivertsen
- Fabia Febbraro
- Duncan S. Sutherland
- Johan Palmfeldt
- Sebastian Diecke
- Olav M. Andersen
- Matthias Selbach
- Thomas E. Willnow
Journal
- Alzheimer's & Dementia
Citation
- Alzheimers Dement 21 (9): e70591
Abstract
INTRODUCTION: Mutations in SORL1, encoding the sorting receptor Sortilin-related receptor with A-type repeats (SORLA), are found in individuals with Alzheimer's disease (AD). We studied SORLA(N1358S), carrying a mutation in its ligand binding domain, to learn more about receptor functions relevant for human brain health. METHODS: We investigated consequences of SORLA(N1358S) expression in induced pluripotent stem cell (iPSC)-derived human neurons and microglia, using unbiased proteome screens and functional cell assays. RESULTS:
We identified alterations in the SORLA(N1358S) interactome linked to biogenesis of exosomes. Consequently, the mutant receptor failed to promote release and neurotrophic qualities of exosomes, a defect attributed to altered exosomal content of microRNAs controlling neuronal maturation. DISCUSSION: We identified a role for SORLA in controlling quantity and neurotrophic quality of exosomes secreted by cells, suggesting impaired cellular cross talk through exosomes as a pathological trait contributing to AD pathology in carriers of SORL1 variants.